Posted On: 11/16/2016 2:47:01 AM
Post# of 22465
Anyone else see this news from Nitto Denko ???
On Thursday, BMS agreed to pay Japanese company Nitto Denko $100 million to license a drug that's being studied to treat advanced liver fibrosis, a condition that's related to liver conditions like hepatitis C and a fatty liver disease called NASH
http://www.businessinsider.com/bristol-myers-...on-2016-11
Now linking previous articles tying quantum dots to curing Fatty Liver Disease
Non Alcoholic Fatty Liver Disease (NAFLD) Worldwide 2016 ... Scientists Develop Non-Toxic Graphene Quantum Dots as MRI ...
https://www.google.com/amp/www.medgadget.com/...ent=safari
Possible connection here????
On Thursday, BMS agreed to pay Japanese company Nitto Denko $100 million to license a drug that's being studied to treat advanced liver fibrosis, a condition that's related to liver conditions like hepatitis C and a fatty liver disease called NASH
http://www.businessinsider.com/bristol-myers-...on-2016-11
Now linking previous articles tying quantum dots to curing Fatty Liver Disease
Non Alcoholic Fatty Liver Disease (NAFLD) Worldwide 2016 ... Scientists Develop Non-Toxic Graphene Quantum Dots as MRI ...
https://www.google.com/amp/www.medgadget.com/...ent=safari
Possible connection here????
(1)
(0)Scroll down for more posts ▼
